Author: @PittsburghPG

HOUSTON, Oct. 24, 2025 (GLOBE NEWSWIRE) — FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced that Founder and Chief Executive Officer, Pete O’Heeron, will present at the Bio-Europe 2025 conference taking place November 3-5, 2025, at the Vienna Congress and ConvRead More

Read More

Canada and India are moving towards improved relations, driven by economic pragmatism and strategic foresight, with Donald Trump’s return to the international stage adding urgency. This thaw follows a period of severe diplomatic strain after the killing of Hardeep Singh Nijjar, with new leaders charting a course that acknowledges past grievances while responding to pressing geopolitical realities.Read More

Read More